Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. - Wikidata - awgldk - TriplyDB

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

http://www.wikidata.org/entity/Q35319079

about

Corticosteroid implants for chronic non-infectious uveitis Corticosteroid implants for chronic non-infectious uveitis Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy Uveitis and gender: the course of uveitis in pregnancy Advances in drug delivery to the posterior segment Management of noninfectious posterior uveitis with intravitreal drug therapy Birdshot retinochoroidopathy Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data.A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.Pharmacotherapy for uveitis: current management and emerging therapy.Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.The transitioning from trials to extended follow-up studies.Success with single-agent immunosuppression for multifocal choroidopathies.Periocular corticosteroid injections in uveitis: effects and complications.Review of Systemic Immunosuppression for Autoimmune Uveitis Systemic therapies for inflammatory eye disease: past, present and future Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.Local therapies for inflammatory eye disease in translation: past, present and future Nanotechnology and nanotoxicology in retinopathy.Clinical trials in noninfectious uveitis Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.Remission of Intermediate Uveitis: Incidence and Predictive Factors Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Tr Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Foll Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Role of the retinal vascular endothelial cell in ocular disease Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy.Uveitic Macular Edema: Treatment Update.Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.Fundus image diagnostic agreement in uveitis utilizing free and open source software Surgical management in patient with uveitis.Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.

P2860

Q24186144-8008E304-FF81-48CD-BD46-0204763F114D Q24198202-EB02E55E-0E68-4EBF-BC11-E76610BC66E2 Q26796779-505A8495-D261-40A8-8AF3-C73452B6919B Q26849299-C218DD64-AAAA-4AF1-BACE-4BF11582C5D7 Q26864267-3A3D0DCF-6667-4DC9-87AE-DAAD96608032 Q26995920-DFA40237-010E-4EE3-A02A-6E957566DC3A Q28074741-0D49021F-1BC0-4BD1-9D44-CFD170F0F878 Q28080595-8A2A8161-4BB9-42B4-BDC5-7B89ADDBCFD1 Q30652690-DE3D6030-B65B-4885-862B-28476D9A21A2 Q34257553-7E0D184B-0106-41BF-A693-B55F5C58C700 Q34258708-29DF235A-7C74-4FE8-A59C-DCA39EF04B5F Q34274075-1E9C1258-2EFF-40BD-8080-F34E7EE0007E Q34444734-AB13B90E-3149-4484-A341-E555C36BFF34 Q34498537-83451999-D0BD-4782-A38A-8E1A06F25154 Q34623981-2FCF29DD-164A-4719-97D9-9DCDA012DFAA Q34624389-DFA8118D-C7C2-450D-9760-CAB18EE354CE Q34627012-02DCF8A4-66BD-4793-BA0E-7E452C232AD1 Q34687332-0EC8EC28-4EF9-4E44-8672-3F113E8A0FC3 Q34786343-16D470D9-8CF7-4D4A-9F34-6BEB3761E515 Q34892662-051B64BB-A529-4748-98C7-719CF54F0CA4 Q35600266-31EF42AE-6AB9-4796-BD0E-5F5B606F2DA7 Q35681664-674B1C94-5C80-482A-AA8F-BBB46E49B885 Q35752563-EC7F212A-9E2D-49CA-A85F-4FE5312F54BD Q35895632-66BB3DCF-5890-4D29-9C22-EFD67FDBCD2B Q36090279-F9B5106F-D79D-4F35-982D-1B8CD7FA36F0 Q36090415-1F933208-58D7-48CD-A3E8-DEE5CE4895C3 Q36218114-5FC892A5-72C5-4A29-A27F-07C68DCFB0C1 Q36228580-0A7F6060-3E62-4298-99E5-71AAE5DEF7AB Q36310489-12242159-322F-4ADC-8C0D-3B9D3A2634E0 Q36354205-6A2B19C0-5564-43A6-8400-98E202C8F043 Q36407719-9D95948D-0C05-4E97-8D6B-5266C0AA551B Q36739472-563C048A-FA41-4037-B93A-26E9DAAA9592 Q36919959-FF54E39C-2818-47EE-A1EB-8B02C5B432A0 Q36929882-DE316B20-6A04-48F1-A1B5-907AFAB1F526 Q37029324-4A91709A-B353-4A51-A1F8-2824D1D28521 Q37038644-E388D42A-F37B-4FD4-8140-CEFB1E4E7261 Q37090612-EFA7FC56-5C29-4CDB-A2DA-69E332221F26 Q37098310-EE670D7C-B33B-465F-82B9-058A13E73FEF Q37135393-04E28EC0-7FEB-4B7F-A277-DD4DD5EAAB6F Q37205804-D2F59E71-5C5A-40B4-963D-4D004E570A5A

P2860

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

http://www.wikidata.org/entity/Q35319079

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Randomized comparison of syste ...... eitis steroid treatment trial.

@ast

Randomized comparison of syste ...... eitis steroid treatment trial.

@en

type

label

Randomized comparison of syste ...... eitis steroid treatment trial.

@ast

Randomized comparison of syste ...... eitis steroid treatment trial.

@en

prefLabel

Randomized comparison of syste ...... eitis steroid treatment trial.

@ast

Randomized comparison of syste ...... eitis steroid treatment trial.

@en

P1433

Q35319079-7E47023B-B04C-460D-8E41-E1C250DB6AED

P1476

Q35319079-CA7246CF-8803-41A8-BF7B-83B8E6AC510C

P2093

Q35319079-4CC649B2-5C40-48E1-90F5-450F0A8F3F28

Q35319079-56AA2176-0A9E-4AFC-9AEA-310ED48B4FAA

Q35319079-8A55CF1D-CD5C-418D-AF27-88A6ECD40E72

Q35319079-91EB6ACC-F679-4438-ACE3-16EAA237BE39

Q35319079-D7DAD83D-EB5C-4AA5-B054-EAC32EDE1BDE

Q35319079-DE947949-5876-498A-A505-429FE5E5B89A

Q35319079-E457361E-D105-4373-B31A-BCE80108AC81

Q35319079-FBD4992B-6980-4E61-B115-F2B58115638F

P2860

Q35319079-15F55FF6-8AE0-42A0-88BC-AD8D5DAED81E

Q35319079-16C91570-F61E-451D-9324-9D37905BC254

Q35319079-1B621FBF-E426-4331-820D-96B421C9BF3D

Q35319079-2235FB85-6958-4C38-B8AA-A9DBFD1E2F86

Q35319079-29046A9B-4B1F-4C5B-ACAB-4155C87AA630

Q35319079-4B8915B3-A115-4DEE-82B1-099A997371F0

Q35319079-5240DB36-74E5-48ED-A6B9-0E7009799241

Q35319079-6E80A5F3-C016-48C6-BBFB-FB708E1DB394

Q35319079-79C29B27-5C8B-443F-A54F-ED7E2C8CF8EC

Q35319079-7A8661E3-96D0-4FBB-B298-8F8DD26E0E55

P304

Q35319079-0C19BABB-7C72-4B60-9BE0-ACC411439794

P31

Q35319079-9B8D4B49-C2CA-4BF5-B339-6669161F8458

P356

Q35319079-0CD6FA5D-360A-4A54-B2BF-7752F6A9D082

P433

Q35319079-49F60D21-7FEF-4A09-BD28-9895955336D9

P478

Q35319079-563B9538-C701-4764-804F-C65838E82E19

P577

Q35319079-FE881176-6290-44E2-9F94-B06E801594F3

P5875

Q35319079-D9184103-47FB-4A86-AAA7-1B64784697FB

P698

Q35319079-F2F8888A-EEFD-4FFF-A9DB-722D1A7E797F

P921

Q35319079-243B36D7-F890-49D5-AB39-AA6FC01F565C

Q35319079-A70A53CD-6512-4F66-BB9E-3CECB67DD593

P932

Q35319079-6E58BA08-13D3-47D8-8342-359347465A25

P356

J.OPHTHA.2011.07.027

P1433

P1476

Randomized comparison of syste ...... eitis steroid treatment trial.

@en

P2093

Douglas A Jabs

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Sugar

http://www.w3.org/2001/XMLSchema#string

Janet T Holbrook

http://www.w3.org/2001/XMLSchema#string

Jennifer E Thorne

http://www.w3.org/2001/XMLSchema#string

John H Kempen

http://www.w3.org/2001/XMLSchema#string

Michael M Altaweel

http://www.w3.org/2001/XMLSchema#string

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

http://www.w3.org/2001/XMLSchema#string

Thomas A Louis

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

A multiple testing procedure for clinical trials

Longitudinal data analysis for discrete and continuous outcomes

EuroQol--a new facility for the measurement of health-related quality of life

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Development of the 25-item National Eye Institute Visual Function Questionnaire.

P304

1916-1926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2011.07.027

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51570498

http://www.w3.org/2001/XMLSchema#string

P698

21840602

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

3191365

http://www.w3.org/2001/XMLSchema#string